Skip Navigation

COVID-19 Update

Find a Doctor

Find a Researcher

Researchers

Christopher Jackson, M.D.

Christopher Mitchell Jackson, M.D.

Photo of Dr. Christopher Jackson, M.D.
  • Assistant Professor of Neurosurgery

Expertise

Acoustic Neuromas, Arteriovenous Malformations (AVM), Brain Tumors, Cerebral Aneurysms, Cerebrovascular Neurosurgery, Gliomas, Meningiomas, Metastatic Brain Tumors, Trigeminal Neuralgia ...read more

Locations

Johns Hopkins Outpatient Center

Appointment Phone: 410-955-6406
601 N. Caroline St.
5th Floor
Baltimore, MD 21287 map

Background

Christopher Jackson, M.D., is a neurosurgeon who sees patients at the Johns Hopkins Outpatient Center. Dr. Jackson specializes in brain tumors and cerebrovascular disorders, including glioma, meningioma, acoustic neuroma, trigeminal neuralgia, brain metastasis, arteriovenous malformation and aneurysm.

Dr. Jackson earned his medical degree from the Johns Hopkins University School of Medicine, where he also completed his neurosurgical residency. During his residency, Dr. Jackson was honored with multiple distinctions, including the Frank L. Coulson Jr. Award for Clinical Excellence, the Irving J. Sherman Award for Resident Achievement, the Harvey Cushing Hunterian Research Award, and was elected to Alpha Omega Alpha.

Dr. Jackson is an active researcher who has published over 35 peer-reviewed articles on brain tumor and cerebrovascular immunology. His laboratory focuses on how brain tumors evade the immune system and become resistant to immunotherapy. Additionally, Dr. Jackson’s laboratory explores the formation of cerebral aneurysms and inflammatory complications of cerebral aneurysm rupture.

...read more

Education

Degrees

  • M.D., Johns Hopkins University School of Medicine (Maryland) (2013)
  • B.A., Wake Forest University (North Carolina) (2008)

Research & Publications

Selected Publications

View all on Pubmed

Jackson, CM., Kochel, CM., Nirschl, CJ., Durham, NM., Ruzevick, J., Alme, A., Francica, BJ., Elias, J., Daniels, A., Dubensky, TW., Lauer, P., Brockstedt, D., Baxi, EG., Calabresi, PA., Taube, JM., Pardo, CA., Brem, H., Pardoll, DM., Lim, M., Drake, CG. Systemic Tolerance Mediated by Melanoma Brain Tumors is Reversible by Radiotherapy and Vaccination. Clinical Cancer Research. 2016: 1516.2015.

Mathios, D., Kim, JE., Mangraviti, A., Phallen, J., Park, C., Jackson, CM., Garzon-Muvdi, T., Kim, E., Theodros, D., Polanczyk, M., Martin, A., Suk, I., Ye, X., Tyler, B., Bettegowda, C., Brem, H., Pardoll, D., Lim, M. Anti-PD-1 antititumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM. Science Translational Medicine. 2016. Dec. 21.(8).

Jackson, CM., Choi, J., Lim, M. Mechanisms of immunotherapy resistance: lessons from glioblastoma. 2019. Nature Immunology. September; 20(9):1100-1109.

Zeng J. See AP, Phallen J, Jackson C, Belcaid Z, Ruzevick J, Durham N, Meyer C, Harris T, Albesiano E, Pradilla G, Ford E, Wong J, Hammers H, Tyler B, Brem H, Tran P, Pardoll D, Drake C, Lim M. Anti-PD-1 blockade and stereotactic radiation produces long-term survivors in mice with intracranial gliomas. International Journal of Radiation Oncology, Biology, Physics. 2013 Feb 22 doi:10.1016/j.ijrobp.2012.12.025.

Ruzevick J, Jackson C, Pradilla G, Garzon-Mudvi T, Tamargo RJ. Role of the haptoglobin protein in carotid artery aneurysm formation. Neurosurgery. 2012. Oct 23.

Activities & Honors

Honors

  • Harvey Cushing Hunterian Research Award, Johns Hopkins University, 2019
  • Alpha Omega Alpha, Johns Hopkins University, 2018
  • Frank L. Collison Jr. Award for Clinical Excellence, Johns Hopkins University, 2019
  • Irving J. Sherman Award for Resident Achievement, Johns Hopkins University, 2018
  • Physician Scientist Training Program, Johns Hopkins University, 2017
Is this you? Edit Profile
back to top button